ECONOMY US Gilead Sciences acquires cancer drug developer Arcellx for $7.8B by Anadolu Agency February 23, 2026 by Anadolu Agency February 23, 2026 ISTANBUL US based biopharmaceutical firm Gilead Sciences announced Monday that it entered into a definitive … Read more 0 FacebookTwitterPinterestEmail
